Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | HRH2 | P25021 | 3/20 | 0.35 |
| ▸ | HRH1 | P35367 | 3/20 | 0.35 |
| ▸ | CMA1 | P23946 | 9/20 | 0.35 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.34 |
| ▸ | ACE | P12821 | 1/20 | 0.34 |
| ▸ | CTRC | Q99895 | 1/20 | 0.33 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8058055 | 0.92 | ELANE (0.36) | ELANEHRH2HRH1CMA1F2 | |
| SCHEMBL8073645 | 0.91 | HRH2 (0.36) | ELANEHRH2HRH1NPSR1ACE | |
| SCHEMBL8080722 | 0.91 | HRH2 (0.36) | ELANEHRH2HRH1NPSR1ACE | |
| SCHEMBL13027124 | 0.84 | GPR119 (0.37) | ELANEHRH2HRH1CMA1F2 | |
| SCHEMBL8073649 | 0.84 | ITGB3 (0.37) | HRH2HRH1 | |
| SCHEMBL8073128 | 0.84 | HRH2 (0.36) | HRH2HRH1 | |
| SCHEMBL8069233 | 0.83 | HRH2 (0.35) | ELANEHRH2HRH1CMA1F2 | |
| SCHEMBL8070526 | 0.77 | ITGB3 (0.43) | HRH2HRH1F2PRSS1 | |
| SCHEMBL2898078 | 0.77 | GPR119 (0.42) | ELANEHRH2HRH1 | |
| SCHEMBL2898073 | 0.77 | GPR119 (0.42) | ELANEHRH2HRH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009034388-A1 | COMPOUNDS FOR THE TREATMENT OF METABOLIC DISORDERS | PROSIDION LIMITED (GB) | 2009-03-19 | — | — | WO | disclosed |